European Heart Journal Advance Access published online on April 28, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi276
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Service de Cardiologie, Hôpital Ambroise Paré, AP-HP, 9 Avenue Charles De Gaulle, Boulogne, France
* To whom correspondence should be addressed. Aims To study the diagnostic value of a new 2D left ventricle hypertrophy (2D LVH) score in families with hypertrophic cardiomyopathy (HCM) in comparison with the conventional maximal wall thickness (MWT) measurement (>13 mm in adults), which is limited by a low sensitivity in relatives. Methods and results The study was performed in 237 adults from genotyped families with HCM. Population A (derivation sample) comprised 109 adults and population B (validation sample) comprised 128 adults. MWT and 2D LVH scores (sum of thicknesses of four segments) were determined by echocardiography. Genotyping was the gold standard for diagnosis. In population A, a theoretical value for LVH score was determined in the healthy population by a multiple linear regression model including age, sex, and body surface area. An abnormal cut-off value was defined as an LVH score above a maximum theoretical value according to receiver operating characteristic analysis. Sensitivity and specificity were, respectively, 73 and 96% for 2D LVH score and 62.5 and 100% for MWT. Improvement of sensitivity was particularly important in adults <50 years of age (69 vs. 54%, respectively, P < 0.04). These results were validated in population B: sensitivity and specificity of LVH score were, respectively, 75 and 96% in this sample and 67 and 97%, in the subgroup <50 years. In the latter, sensitivity of LVH score increased when compared with that of MWT (67 vs. 53%, P < 0.03). Conclusions The LVH score has a higher diagnostic value for HCM than the conventional criterion of MWT, particularly in young adults. This echographic parameter may be proposed as an alternative diagnostic criterion for familial screening.
Received July 29, 2004
Revised March 4, 2005
Accepted March 18, 2005
Clinical research
Diagnostic accuracy of a 2D left ventricle hypertrophy score for familial hypertrophic cardiomyopathy
2 Département de Génétique, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France; Service de Biostatistique et d'Information Médicale, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
3 Département de Cardiologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
4 Service de Cardiologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France
5 Inserm U582, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
6 Service de Biochimie B, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
7 Service de Cardiologie, Hôpital Laënnec, Nantes, France
Olivier Dubourg, E-mail: olivier.dubourg{at}apr.ap-hop-paris.fr
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I A Paraskevaidis, F Panou, C Papadopoulos, D Farmakis, J Parissis, I Ikonomidis, A Rigopoulos, E K Iliodromitis, and D Th Kremastinos Evaluation of left atrial longitudinal function in patients with hypertrophic cardiomyopathy: a tissue Doppler imaging and two-dimensional strain study Heart, March 15, 2009; 95(6): 483 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. Nagueh and J. J. Mahmarian Noninvasive Cardiac Imaging in Patients With Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., December 19, 2006; 48(12): 2410 - 2422. [Abstract] [Full Text] [PDF]
|
|